Huang et al. found that sesamin inhibited colorectal cancer angiogenesis by targeting the NF-κB/HIF-1α/VEGFA signaling pathway, suggesting its potential in the prevention and treatment of colorectal cancer [30]. The gene discussed is NFKB1; the disease is colorectal cancer.